Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Citi
Fuji
Johnson and Johnson
Teva
Mallinckrodt
Julphar
Baxter
Boehringer Ingelheim

Generated: June 20, 2018

DrugPatentWatch Database Preview

SERZONE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Serzone patents expire, and what generic alternatives are available?

Serzone is a drug marketed by Bristol Myers Squibb and is included in one NDA.

The generic ingredient in SERZONE is nefazodone hydrochloride. There are four drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the nefazodone hydrochloride profile page.
Summary for SERZONE
Drug patent expirations by year for SERZONE
Synonyms for SERZONE
1-(3-(4-(3-Chlorophenyl)piperazin-1-yl)propyl)-3-ethyl-4-(2-phenoxyethyl)-1H-1,2,4-triazol-5(4H)-one hydrochloride
1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta(sup 2)-1,2,4-triazolin-5-one monohydrochloride
2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-ethyl- 2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one hydrochloride
2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3h-1,2,4-triaz
2-[3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl]-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one hydrochloride
2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-ethyl-4-(2-phenoxyethyl)-1,2,4-triazol-3-one hydrochloride
2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-ethyl-4-(2-phenoxyethyl)-2H-1,2,4-triazol-3(4H)-one hydrochloride
2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-5-ethyl-4-(2-phenoxyethyl)-1,2,4-triazol-3-one hydrochloride
2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-5-ethyl-4-(2-phenoxyethyl)-1,2,4-triazol-3-one;hydrochloride
2-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-5-ethyl-4-(2-phenoxyethyl)-2,4-dihydro-3H-1,2,4-triazol-3-one hydrochloride
27X63J94GR
3H-1,2,4-Triazol-3-one, 2-(3-(4-(3-chlorophenyl)-1-piperazinyl))propyl)-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-, monohydrochloride
3H-1,2,4-Triazol-3-one, 2-(3-(4-(3-chlorophenyl)-1-piperazinyl)propyl)-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-, monohydrochloride
752N996
82752-99-6
83366-66-9 (Parent)
A840427
AB0012498
AC-1373
AC1L1HZ6
AK-72861
AKOS015846321
AN-14998
ANW-44895
API0003524
AX8232012
B7183
BG0403
BMY 13754
BMY 13754-1
BMY-13754
BMY-13754-1
BR-72861
C25H32ClN5O2.HCl
C25H33Cl2N5O2
CAS-82752-99-6
CCG-100923
CHEBI:7495
CHEMBL1200492
CPD000449297
CS-4860
CTK8B4390
D00819
DSSTox_CID_26088
DSSTox_GSID_46088
DSSTox_RID_81328
DTXSID8046088
Dutonin
DYCKFEBIOUQECE-UHFFFAOYSA-N
FT-0601548
HY-B1396
I14-2088
J10172
KB-213403
KS-00001FBT
KS-1088
LS-156498
Menfazona
MFCD00935760
MJ 13,754-1
MJ 13754-1
MJ-13754-1
MLS000758241
MLS000759458
MLS001401457
MolPort-003-983-466
NC00173
NCGC00165846-02
NCGC00165846-04
Nefadar
Nefazodone (hydrochloride)
Nefazodone Hcl
nefazodone hydrochlo
NEFAZODONE HYDROCHLORIDE
Nefazodone hydrochloride (USAN)
Nefazodone hydrochloride [USAN]
Nefazodone Hydrochloride 1.0 mg/ml in Methanol (as free base)
Nefazodone hydrochloride, >=98% (HPLC), solid
Nefazodone hydrochloride, United States Pharmacopeia (USP) Reference Standard
nefazodone-d5 hcl
Nefazodone(hydrochloride)
Reseril
Rulivan
SAM001246653
SAM001247036
SC-18178
SCHEMBL41119
Serazone
Serzone (TN)
SMR000449297
ST24021030
ST51054152
TL8005461
Tox21_111735
Tox21_111735_1
Tox21_113574
TR-025850
UNII-27X63J94GR
VA11367

US Patents and Regulatory Information for SERZONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb SERZONE nefazodone hydrochloride TABLET;ORAL 020152-001 Dec 22, 1994 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bristol Myers Squibb SERZONE nefazodone hydrochloride TABLET;ORAL 020152-004 Dec 22, 1994 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bristol Myers Squibb SERZONE nefazodone hydrochloride TABLET;ORAL 020152-002 Dec 22, 1994 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bristol Myers Squibb SERZONE nefazodone hydrochloride TABLET;ORAL 020152-003 Dec 22, 1994 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for SERZONE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bristol Myers Squibb SERZONE nefazodone hydrochloride TABLET;ORAL 020152-002 Dec 22, 1994 ➤ Try a Free Trial ➤ Try a Free Trial
Bristol Myers Squibb SERZONE nefazodone hydrochloride TABLET;ORAL 020152-003 Dec 22, 1994 ➤ Try a Free Trial ➤ Try a Free Trial
Bristol Myers Squibb SERZONE nefazodone hydrochloride TABLET;ORAL 020152-004 Dec 22, 1994 ➤ Try a Free Trial ➤ Try a Free Trial
Bristol Myers Squibb SERZONE nefazodone hydrochloride TABLET;ORAL 020152-001 Dec 22, 1994 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Harvard Business School
Farmers Insurance
Queensland Health
McKinsey
Cipla
Daiichi Sankyo
McKesson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.